Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

AOD-9604 Metabolic.

John Wilding1

  • 1Diabetes and Endocrinology Research Group, Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool, L9 7AL, UK. j.p.h.wilding@liv.ac.uk

Current Opinion in Investigational Drugs (London, England : 2000)
|May 12, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SURMOUNT-REAL UK: A Pragmatic Randomized Clinical Trial to Assess the Effectiveness of Tirzepatide in Adults With Obesity.

Obesity (Silver Spring, Md.)·2026
Same author

International expert consensus on definitions and management of weight recurrence and suboptimal response after metabolic and bariatric surgery: a Delphi study.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2026
Same author

Real-world completion of diabetes self management education and its impact on patient-reported outcomes: A scoping review.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Diabetes self-management education and its association with hospital admissions and premature mortality: A scoping review and meta-analysis.

Diabetes, obesity & metabolism·2025
Same author

Rising to the challenges of research in multiple long-term conditions: health and social care research ecosystem approaches.

BMJ open·2025
Same author

EndoBridge 2024: pearls and highlights.

Hormones (Athens, Greece)·2025

Metabolic is investigating AOD-9604, a potential obesity treatment. Phase IIa clinical trials were ongoing as of February 2002 to assess its efficacy.

Area of Science:

  • Pharmacology
  • Metabolic Disorders
  • Clinical Trials

Background:

  • Obesity is a complex metabolic disorder with significant health implications.
  • Current treatments for obesity have limitations in efficacy and safety.
  • AOD-9604 is a novel compound being developed for weight management.

Purpose of the Study:

  • To evaluate the potential of AOD-9604 as a therapeutic agent for obesity.
  • To assess the safety and preliminary efficacy of AOD-9604 in human subjects.

Main Methods:

  • Phase IIa clinical trials were initiated by February 2002.
  • The study involves administering AOD-9604 to participants with obesity.

Main Results:

  • Preliminary data from ongoing trials are expected.

Related Experiment Videos

  • Further results will determine the compound's therapeutic value.

    • Conclusions:

    • AOD-9604 shows promise as a potential treatment for obesity.
    • Continued research and clinical trials are necessary to confirm its effectiveness.